These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 28959461)
1. Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial. Wang D; Gui L; Dong Y; Li H; Li S; Zheng H; Wang A; Meng X; Liu LP; Wang YL; Wang G; Jing J; Li Z; Zhao XQ; Wang YJ Stroke Vasc Neurol; 2016 Jun; 1(2):29-36. PubMed ID: 28959461 [TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777 [TBL] [Abstract][Full Text] [Related]
3. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481 [TBL] [Abstract][Full Text] [Related]
4. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial. Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y; Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381 [TBL] [Abstract][Full Text] [Related]
5. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y; J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965 [TBL] [Abstract][Full Text] [Related]
6. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack. Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Li Y; Liu J; Wang Y; Ann Neurol; 2022 Mar; 91(3):380-388. PubMed ID: 34951042 [TBL] [Abstract][Full Text] [Related]
7. Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission. Scavasine VC; Barbosa RM; Lopes Neto FDN; Germininani FMB; Bazan R; Zétola VF; Massaro AR; Lange MC J Stroke Cerebrovasc Dis; 2021 May; 30(5):105677. PubMed ID: 33677312 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study. Hou X; Li X; Wang X; Chen H Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study. Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754 [TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial. Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084 [TBL] [Abstract][Full Text] [Related]
11. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y; N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499 [TBL] [Abstract][Full Text] [Related]
12. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials. Ahmed M; Ahsan A; Fatima L; Basit J; Nashwan AJ; Ali S; Hamza M; Karalis I; Ahmed R; Alareed A; Ijioma NN; Alraies MC Vasc Med; 2024 Oct; 29(5):517-525. PubMed ID: 39164077 [No Abstract] [Full Text] [Related]
14. Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES). Gao Y; Pan Y; Han S; Chen W; Jing J; Wang C; Yang Y; Wang T; Meng X; Zhao X; Liu L; Li H; Johnston SC; Amarenco P; Bath PM; Wang Y; Wang Y; Stroke Vasc Neurol; 2023 Jun; 8(3):249-258. PubMed ID: 36707080 [TBL] [Abstract][Full Text] [Related]
15. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial. Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T; Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237 [TBL] [Abstract][Full Text] [Related]
16. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE]. Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332 [No Abstract] [Full Text] [Related]
17. Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS. Cui Y; Liu QY; Chen HS J Am Heart Assoc; 2024 Sep; 13(18):e036318. PubMed ID: 39248249 [TBL] [Abstract][Full Text] [Related]
18. Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack. Guan L; Han S; Johnston SC; Bath PM; Amarenco P; Yang Y; Wang T; Jing J; Wang C; Gao Y; Chen W; Yan H; Wang X; Wang Y; Wang Y; Pan Y Neurology; 2024 Oct; 103(7):e209845. PubMed ID: 39270151 [TBL] [Abstract][Full Text] [Related]
19. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY; N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750 [TBL] [Abstract][Full Text] [Related]
20. Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack. Huang HY; Chen JH; Chi NF; Chen YC J Atheroscler Thromb; 2024 Jun; 31(6):904-916. PubMed ID: 38092384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]